Mylan Pharmaceuticals Inc v. Sanofi-Aventis U.S. LLC

Court

District Court, W.D. Pennsylvania (W.D. Pa.)
Official Court Website →

Assigned judge

Mark R. Hornak · 1,191 cases in index

Docket number

2:23-cv-00836

Cause

15:2 Antitrust Litigation
15 U.S.C. § 2 — Sherman Act (monopolization)

Nature of suit

410 Anti-Trust
Claims of unlawful restraint of trade, monopolization, or anticompetitive conduct under the Sherman and Clayton Acts.

Jurisdiction

Federal Question

Jury demand

Plaintiff

Date filed

05/18/2023

384 Antitrust cases in this court are indexed here.

Parties

• plaintiff · Mylan Pharmaceuticals, Inc · 388 cases
• defendant · Sanofi-Aventis U.S. LLC · 688 cases

Part of a Larger Litigation Pattern

This is one of 689 Antitrust cases in our index naming Sanofi-Aventis U.S. LLC — a possible mass-tort or coordinated-litigation cluster.

• Mosaic Health, Inc v. Sanofi-Aventis U.S., LLC
  District Court, W.D. New YorkFiled 07/30/2021
• Sanofi-Aventis U.S. LLC v. Mylan Inc
  District Court, D. New JerseyFiled 04/24/2017
• Eisai Inc v. Sanofi-Aventis U.S., LLC
  District Court, D. New JerseyFiled 08/18/2008

About Antitrust Lawsuits

Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

Frequently Asked Questions

What is Mylan Pharmaceuticals Inc v. Sanofi-Aventis U.S. LLC?

Mylan Pharmaceuticals Inc v. Sanofi-Aventis U.S. LLC is a federal antitrust lawsuit filed on 05/18/2023 in the District Court, W.D. Pennsylvania. The case is currently open in the federal court system. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

What type of case is this?

It is classified as “Antitrust” under the federal nature-of-suit system. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

What court is the case in?

The case is in the District Court, W.D. Pennsylvania, docket number 2:23-cv-00836.

When was the case filed?

Mylan Pharmaceuticals Inc v. Sanofi-Aventis U.S. LLC was filed on 05/18/2023. The case is currently open.

What law is the case brought under?

The docket lists the cause as 15 U.S.C. § 2 — Sherman Act (monopolization).